Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
Status:
Terminated
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Escitalopram may help improve depression and quality of life in patients with
advanced lung or gastrointestinal cancer. It is not yet known whether escitalopram is more
effective than a placebo in treating depression in patients with advanced lung or
gastrointestinal cancer.
PURPOSE: This randomized clinical trial is studying the side effects of escitalopram and to
see how well it works compared to a placebo in treating depression in patients with advanced
lung or gastrointestinal cancer.